Revenue AccelerationSustained revenue acceleration across recent years signals improving commercial traction and growing product adoption. If maintained, higher top-line momentum supports operating leverage, validates market fit for X‑ray offerings and improves the path to break‑even over a multi‑quarter horizon.

Low Leverage / Balance Sheet CushionMinimal reported debt and sizable equity versus assets reduce near‑term solvency risk and give management flexibility. A low‑leverage profile lengthens runway versus highly indebted peers, easing refinancing pressure while the company pursues revenue growth or R&D.

Medical Imaging FocusOperating in medical X‑ray technology places the company in a structurally resilient healthcare segment with steady clinical demand and long replacement cycles. Durable demand dynamics for diagnostic imaging support sustained revenue opportunities if product execution continues.

Bears Say

Persistent Net LossesMaterial and ongoing net losses indicate the business is not yet generating sustainable profits. Persistent losses erode retained earnings, limit reinvestment capacity, and mean profitability must improve materially or the firm will remain dependent on external capital over the medium term.

Negative Operating Cash FlowConsistently negative operating cash flow shows the core business consumes cash rather than generates it. This structural cash burn requires repeated funding rounds or asset draws, increasing dilution or financing risk and constraining long‑term investment and scaling prospects.

Volatile / Negative Gross MarginsErratic and occasionally negative gross margins point to unstable unit economics or cost structure issues. Without margin stabilization, revenue growth may not translate into profits, limiting operating leverage and making sustainable business model economics uncertain over the medium term.

LUR FAQ

What was Luxbright AB’s price range in the past 12 months?

Luxbright AB lowest stock price was €0.02 and its highest was €0.07 in the past 12 months.

What is Luxbright AB’s market cap?

Luxbright AB’s market cap is €5.32M.

When is Luxbright AB’s upcoming earnings report date?

Luxbright AB’s upcoming earnings report date is Aug 14, 2026 which is in 172 days.

How were Luxbright AB’s earnings last quarter?

Luxbright AB released its earnings results on Jan 30, 2026. The company reported -€0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.007.

Is Luxbright AB overvalued?

According to Wall Street analysts Luxbright AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Luxbright AB pay dividends?

Luxbright AB does not currently pay dividends.

What is Luxbright AB’s EPS estimate?

Luxbright AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Luxbright AB have?

Luxbright AB has 130,148,010 shares outstanding.

What happened to Luxbright AB’s price movement after its last earnings report?

Luxbright AB reported an EPS of -€0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -11.905%.

Which hedge fund is a major shareholder of Luxbright AB?

Currently, no hedge funds are holding shares in DE:LUR

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Luxbright AB

Luxbright AB (publ), a technology company, develops and commercializes X-ray tubes, generators, and X-ray systems to system suppliers. The company was incorporated in 2012 and is headquartered in Gothenburg, Sweden.